Advertisement

Dental Technology

Researchers developing a tooth regeneration drug are set to conduct the first human trial for the drug, according to a June 23 report by Fox 5.

Dental laser company Biolase was recently delisted from Nasdaq for failure to meet certain requirements, effective June 20.

Advertisement
Advertisement